Alison Crawford
3PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 09, 2024
Translational findings support regimen selection for first-in-human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer.Min Zhu, Priyanka Madia, Alison Crawford
|Jan 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.Dimitris Skokos, Janelle C Waite, Lauric Haber
|Jun 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer.Alison Crawford, Lauric Haber, Marcus P Kelly
Pageof 1
Frequent Collaborators
2 joint publications
Danica Chiu
2 joint publications
Pamela Krueger
2 joint publications
Douglas MacDonald
2 joint publications
Jessica R Kirshner
2 joint publications
Lauric Haber
1 joint publications
Jennifer Finney
1 joint publications
Curtis A Colleton
1 joint publications
Elena Garnova
1 joint publications
Jessica Kuhnert
1 joint publications
Dimitris Skokos
